Susanne has been in the life sciences industry for over 20 years focused on rare diseases and specialty
products. During her 9 years at Achillion, she has held a wide range of responsibilities including
commercial readiness, business development and new product strategy.
In her current role as Senior Vice President, Susanne specializes in setting commercial strategy focused
on the complement space. In addition, she heads the patient advocacy and corporate communications
efforts for Achillion.
Prior to Achillion, Susanne worked for start-up companies Lev Pharmaceuticals focused on Cinryze and
Ora Pharma Inc. focused on Arestin where she gained commercial experience including pricing,
reimbursement, sales management, marketing and launch strategy. Both companies were subsequently
acquired enabling Susanne to expand her commercial skills within larger life science organizations.
Susanne has a Bachelor of Business Administration in Accounting from Texas Tech University and a
Master of Business Administration from Saint Joseph’s Haub School of Business. Susanne recently
moved back to her hometown of Houston, Texas after residing in New York City for 13 years.